breseq  version 0.33.1  revision 8505477f25b3
mutation predictions | marginal predictions | summary statistics | genome diff | command line log

Marginal read alignment evidence
  seq id position ref new freq score (cons/poly) reads annotation genes product
*USA300TCH1516_ALE512,6430AG46.4% 27.3 / 163.2 112intergenic (+711/‑6052)recR/speA_2Recombination protein RecR/Arginine decarboxylase
*USA300TCH1516_ALE111,5120AG37.5% 53.7 / 72.1 64S194S (TCA→TCGUSA300HOU_RS00520putative lipoprotein
*USA300TCH1516_ALE111,5160CA37.5% 81.2 / 73.5 64Q196K (CAA→AAA) USA300HOU_RS00520putative lipoprotein

Marginal new junction evidence (sorted from low to high skew)
  seq id position reads (cov) reads (cov) score skew freq annotation gene product
* ? USA300TCH1516_ALE 2085296 =65 (1.280)8 (0.180) 7/252 3.2 15.5% coding (173/201 nt) hlb_1 Phospholipase C
?USA300TCH1516_ALE = 2128343 29 (0.630)coding (1/825 nt) hlb_2 Phospholipase C
* ? USA300TCH1516_ALE 2457361 =64 (1.260)4 (0.090) 3/254 4.9 7.8% intergenic (+40/+196) USA300HOU_RS12645/mro hypothetical protein/Aldose 1‑epimerase
?USA300TCH1516_ALE 2457434 = 37 (0.800)intergenic (+113/+123) USA300HOU_RS12645/mro hypothetical protein/Aldose 1‑epimerase
* ? USA300TCH1516_ALE 1502317 =57 (1.120)3 (0.060) 3/270 5.1 5.3% intergenic (‑294/+104) ebh_1/norB_4 Extracellular matrix‑binding protein ebh/Quinolone resistance protein NorB
?USA300TCH1516_ALE 1502366 = 52 (1.060)intergenic (‑343/+55) ebh_1/norB_4 Extracellular matrix‑binding protein ebh/Quinolone resistance protein NorB
* ? USA300TCH1516_ALE = 80092852 (1.020)3 (0.060) 3/266 5.1 6.2% intergenic (+62/‑289) hisC_1/USA300HOU_RS03915 Histidinol‑phosphate aminotransferase/Putative 5'(3')‑deoxyribonucleotidase
?USA300TCH1516_ALE 801948 = 42 (0.870)intergenic (+189/+435) USA300HOU_RS03915/USA300HOU_RS03920 Putative 5'(3')‑deoxyribonucleotidase/Putative lipid kinase
* ? CP000731 = 4399155 (0.980)8 (0.010) 4/258 13.4 1.0% intergenic (+364/‑101) USA300HOU_pUSA300HOUMR0006/cadR hypothetical protein/cadmium binding protein
?NC_012417 = 1963 1436 (1.030)intergenic (+196/+130) USA300HOU_RS14895/USA300HOU_RS14900 hypothetical protein/hypothetical protein
* ? CP000731 = 2352168 (1.070)8 (0.010) 4/258 13.4 1.00% intergenic (+132/+36) USA300HOU_pUSA300HOUMR0003/USA300HOU_pUSA300HOUMR0004 hypothetical protein/hypothetical protein
?NC_012417 = 1963 1436 (1.030)intergenic (+196/+130) USA300HOU_RS14895/USA300HOU_RS14900 hypothetical protein/hypothetical protein
* ? CP000731 = 4419161 (1.020)7 (0.010) 3/264 14.4 0.86% intergenic (+384/‑81) USA300HOU_pUSA300HOUMR0006/cadR hypothetical protein/cadmium binding protein
?NC_012417 = 1946 1468 (1.030)intergenic (+179/+147) USA300HOU_RS14895/USA300HOU_RS14900 hypothetical protein/hypothetical protein
* ? CP000731 = 2372159 (1.010)7 (0.010) 3/264 14.4 0.86% intergenic (+152/+16) USA300HOU_pUSA300HOUMR0003/USA300HOU_pUSA300HOUMR0004 hypothetical protein/hypothetical protein
?NC_012417 = 1946 1468 (1.030)intergenic (+179/+147) USA300HOU_RS14895/USA300HOU_RS14900 hypothetical protein/hypothetical protein
* ? NC_012417 = 19741590 (1.050)8 (0.010) 5/258 55.7 0.55% intergenic (+207/+119) USA300HOU_RS14895/USA300HOU_RS14900 hypothetical protein/hypothetical protein
?NC_012417 = 2041 1448 (1.040)intergenic (+274/+52) USA300HOU_RS14895/USA300HOU_RS14900 hypothetical protein/hypothetical protein
* ? NC_012417 = 19541520 (1.000)6 (0.000) 3/264 58.5 0.42% intergenic (+187/+139) USA300HOU_RS14895/USA300HOU_RS14900 hypothetical protein/hypothetical protein
?NC_012417 = 2064 1391 (0.970)intergenic (+297/+29) USA300HOU_RS14895/USA300HOU_RS14900 hypothetical protein/hypothetical protein